Literature DB >> 18538402

One-year outcomes with new-generation multifocal intraocular lenses.

Salvatore Cillino1, Alessandra Casuccio, Francesco Di Pace, Raffaella Morreale, Francesco Pillitteri, Giovanni Cillino, Gaetano Lodato.   

Abstract

PURPOSE: To compare new-generation multifocal intraocular lenses (IOLs) with monofocal IOLs.
DESIGN: Randomized prospective clinical trial. PARTICIPANTS: Sixty-two consecutive patients with cataract, seen between January of 2005 and January of 2006 at the Department of Ophthalmology of Palermo University Hospital in Italy, were bilaterally implanted with monofocal (AR 40, Advanced Medical Optics [AMO], Santa Ana, CA; 15 patients), multifocal refractive (Array SA40N, AMO; 16 patients), multifocal refractive (ReZoom, AMO; 15 patients), or multifocal diffractive pupil-independent (Tecnis ZM900, AMO; 16 patients) IOLs. INTERVENTION: Bimanual phacoemulsification. MAIN OUTCOME MEASURES: Primary outcomes were far, near, and intermediate visual acuity of the 4 IOL-implanted groups. Secondary outcomes were defocusing curves, contrast sensitivity, patients' quality of life (7-item visual function questionnaire [VF-7], halos and glare presence, overall satisfaction), and spectacle independence. Snellen visual acuity was measured as uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), uncorrected near visual acuity (UCNVA), best distance corrected near visual acuity (BDCNVA), best corrected near visual acuity (BCNVA), uncorrected intermediate visual acuity (UCIVA), and best distance corrected intermediate visual acuity (BDCIVA).
RESULTS: UCNVA was 20/50 in the monofocal IOL group, compared with 20/32 or better in the multifocal IOL groups (P<0.0005). The monofocal IOL group exhibited a lower BDCNVA than the multifocal IOL groups (P<0.0005). The diffractive multifocal IOL group performed better than either refractive group (P = 0.007). UCIVA was significantly different (P = 0.001) among the groups: monofocal (AR 40) 20/32; multifocal refractive (Array SA40N) 20/30; multifocal refractive (ReZoom) 20/25; and multifocal diffractive (Tecnis ZM900) 20/30. Defocusing curves with -3.00 diopter lens exhibited a better trend in the diffractive group. The refractive multifocal IOL groups exhibited lower contrast sensitivities at 3 cycles/degree (P = 0.038). The VF-7 mean score was significantly lower in the monofocal than the multifocal IOL groups (P = 0.002). Night halos were more common in the refractive groups (P<0.01). Spectacle independence was 20% in the monofocal IOL group, 43.7% and 53.3% in the refractive multifocal IOL groups, and 87.5% in the diffractive multifocal IOL group (P<0.05).
CONCLUSIONS: Multifocal IOLs provide a greater depth of focus and higher patient satisfaction, and make intermediate and near visual tasks easier than do monofocal lenses. New-generation, diffractive, pupil-independent multifocal IOLs provide better near vision, equivalent intermediate vision, less unwanted photic phenomena, and greater spectacle independence than either monofocal or refractive multifocal IOLs.

Entities:  

Mesh:

Year:  2008        PMID: 18538402     DOI: 10.1016/j.ophtha.2008.04.017

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  54 in total

Review 1.  Premium intraocular lenses use in patients with cataract and concurrent glaucoma: a review.

Authors:  Raluca Iancu; Catalina Corbu
Journal:  Maedica (Buchar)       Date:  2013-09

2.  Predictive factor and kappa angle analysis for visual satisfactions in patients with multifocal IOL implantation.

Authors:  G Prakash; D R Prakash; A Agarwal; D A Kumar; A Agarwal; S Jacob
Journal:  Eye (Lond)       Date:  2011-06-17       Impact factor: 3.775

3.  The clinical depth of field achievable with trifocal and monofocal intraocular lenses: theoretical considerations and proof of concept clinical results.

Authors:  Ante Barišić; Sudi Patel; Nikica Gabric; Claes G Feinbaum
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-24       Impact factor: 3.117

4.  Retinal detachment repair through multifocal intraocular lens- overcoming visualization challenge of the peripheral retina.

Authors:  Amir Hadayer; Denis Jusufbegovic; Shlomit Schaal
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

5.  Perceived image quality with simulated segmented bifocal corrections.

Authors:  Carlos Dorronsoro; Aiswaryah Radhakrishnan; Pablo de Gracia; Lucie Sawides; Susana Marcos
Journal:  Biomed Opt Express       Date:  2016-10-03       Impact factor: 3.732

Review 6.  Multifocal versus monofocal intraocular lenses after cataract extraction.

Authors:  Samantha R de Silva; Jennifer R Evans; Varo Kirthi; Mohammed Ziaei; Martin Leyland
Journal:  Cochrane Database Syst Rev       Date:  2016-12-12

7.  Measuring benefits and patients' satisfaction when glasses are not needed after cataract and presbyopia surgery: scoring and psychometric validation of the Freedom from Glasses Value Scale (FGVS).

Authors:  Gilles Berdeaux; Juliette Meunier; Benoit Arnould; Muriel Viala-Danten
Journal:  BMC Ophthalmol       Date:  2010-05-24       Impact factor: 2.209

8.  Wavefront analysis and modulation transfer function of three multifocal intraocular lenses.

Authors:  Marcony R Santhiago; Marcelo V Netto; Jackson Barreto; Beatriz A F Gomes; Arthur Schaefer; Newton Kara-Junior
Journal:  Indian J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 1.848

9.  Visual Performance of Tecnis ZM900 Diffractive Multifocal IOL after 2500 Implants: A 3-Year Followup.

Authors:  Leonardo Akaishi; Rodrigo Vaz; Graziela Vilella; Rodrigo C Garcez; Patrick F Tzelikis
Journal:  J Ophthalmol       Date:  2010-10-05       Impact factor: 1.909

10.  A contralateral eye study comparing apodized diffractive and full diffractive lenses: wavefront analysis and distance and near uncorrected visual acuity.

Authors:  Marcony Rodrigues de Santhiago; Marcelo Vieira Netto; Jackson Barreto; Beatriz de Abreu Fiuza Gomes; Arthur Schaefer; Newton Kara-Junior
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.